European Equities Traded in the US as American Depositary Decline in Tuesday Trading

European equities traded in the US as American depositary receipts were moving lower late Tuesday morning, declining 0.37% to 1,317.16 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies (DBVT) and Cellectis (CLLS), which climbed 14% and 4.6% respectively. They were followed by furniture maker Natuzzi (NTZ) and pharmaceutical company Novo Nordisk (NVO), which rose 4.1% and 1.8% respectively.

The decliners from continental Europe were led by biopharmaceutical company Genfit (GNFT) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which fell 8.4% and 2.6% respectively. They were followed by petroleum refiner Equinor (EQNR) and medical device maker EDAP TMS (EDAP), which lost 2% each.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company NuCana (NCNA), which increased 6% each. They were followed by biotech firm Autolus Therapeutics (AUTL) and cruise line operator Carnival (CUK), which were up 4.7% and 1.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and TC Biopharm (TCBP), which fell 10% and 5.9% respectively. They were followed by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Amarin (AMRN), which were down 4.8% and 2.5% respectively.